Vestcor Inc - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Vestcor Inc ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$4,036
-99.9%
400,0000.0%0.15%
-1.3%
Q3 2022$3,964,000
+1.0%
400,0000.0%0.15%
+2.7%
Q2 2022$3,924,0000.0%400,0000.0%0.15%
+8.1%
Q1 2022$3,924,000
+1.1%
400,0000.0%0.14%
-1.5%
Q4 2021$3,880,000
+0.1%
400,0000.0%0.14%
-2.1%
Q3 2021$3,876,000
+0.2%
400,0000.0%0.14%
+6.9%
Q2 2021$3,868,000400,0000.13%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Integrity Capital Management (HK) Ltd 46,717$454,0001.44%
Lynwood Capital Management Inc. 51,401$515,0000.49%
TEGEAN CAPITAL MANAGEMENT, LLC 91,422$888,0000.46%
HRS Investment Holdings, LLC 112,050$1,087,0000.36%
DARK FOREST CAPITAL MANAGEMENT LP 96,740$940,0000.35%
BASSO CAPITAL MANAGEMENT, L.P. 170,114$1,654,0000.18%
SPRING CREEK CAPITAL LLC 400,000$3,880,0000.15%
Vestcor Inc 400,000$3,880,0000.14%
Castle Creek Arbitrage, LLC 253,446$2,458,0000.12%
Knott David M Jr 36,000$348,0000.12%
View complete list of IBERE PHARMACEUTICALS shareholders